Myasthenia gravis (MG) is a infrequent nerve-muscle disease characterized by muscle weakness and tiredness . It occurs when the communication between nerves and muscle tissue is broken. This interruption is typically due to antibodies attacking the connection point where nerves and muscle fibers meet – the neuromuscular connection. Consequently,

Ketoconazole has become a leading antifungal compound. This potent medication effectively targets a wide variety of fungal infections, making it a crucial tool in the fight against these detrimental conditions. Its skill to inhibit ergosterol biosynthesis, a vital component of fungal cell membranes, causes in significant reduction of fungal growth.